Everest Medicines Announces South Korea Grants Fast-Track Review Designation to Nefecon for Primary IgA Nephropathy Treatment
Everest Medicines, a biopharmaceutical company developing and commercializing innovative pharmaceuticals and vaccines in Asia, has received Global Innovative product on Fast Track (GIFT) designation f ...